CBT for Insomnia
vs
Hot Flash Pills

A side-by-side comparison of two menopause relief methods — efficacy, cost, how they work, and who shouldn't use them.

Side-by-side comparison

Method
CBT for Insomnia

CBT for Insomnia

A structured talk therapy program that improves sleep during menopause by changing sleep habits and unhelpful thoughts about sleep.
Hot Flash Pills

Hot Flash Pills

A daily prescription pill (neurokinin receptor antagonist) that blocks NK3 receptors in the brain to reduce hot flashes and night sweats.
EfficacyRecommended see details

Recommended by the Menopause Society for symptom relief.

Recommended see details

Recommended by the Menopause Society for symptom relief.

Cost$0–$200 /per unit

Insurance: Usually

$0–$780 /monthly

Insurance: Usually

Duration6-8 sessions over 8 weeksDaily pill (ongoing)
ReversibilityReversibleReversible
STI ProtectionNoNo
How it works

Cognitive Behavioral Therapy for Insomnia (CBT-I) combines sleep restriction (limiting time in bed to build sleep drive), stimulus control (associating the bed only with sleep), sleep hygiene education, cognitive restructuring (challenging unhelpful beliefs about sleep), and relaxation techniques. It targets the behavioral and cognitive patterns that maintain insomnia, rather than using medication.

Blocks neurokinin-3 (NK3) and/or neurokinin-1 (NK1) receptors in the hypothalamus to interrupt the temperature-regulation pathway that triggers hot flashes and night sweats.

PrescriptionOTC Therapist-delivered (no Rx)Required Prescription required
Available ProductsNo branded products yet2 products
Side effects
  • Temporary daytime sleepiness during initial sleep restriction phase
  • Short-term increase in fatigue as sleep window is narrowed
  • Elevated liver enzymes (requires monitoring)
  • Abdominal pain
  • Diarrhea
  • Insomnia
  • Back pain
  • Hot flush
  • Headache
  • Somnolence, dizziness, and fatigue (more common with dual NK1/NK3 antagonists)
Who shouldn't use this
  • Untreated sleep apnea (address apnea first)
  • Active mania or psychosis (CBT-I is not appropriate during acute psychiatric crises)
  • Shift work sleep disorder (CBT-I is designed for chronic insomnia, not circadian rhythm disorders)
  • Cirrhosis or severe liver disease (NK3 antagonists such as fezolinetant)
  • Severe renal impairment or end-stage renal disease (NK3 antagonists such as fezolinetant)
  • Concomitant use of CYP1A2 inhibitors such as fluvoxamine or ciprofloxacin (NK3 antagonists such as fezolinetant)
  • Pregnancy (dual NK1/NK3 antagonists such as elinzanetant)